Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Wins Pivotal Phase III Approval, Set to Reshape the Frontline Treatment Landscape for Advanced EP-NEC NANJING, China, May 19, 2026 /PRNewswire/ — Nanjing Leads Biolabs Co., Ltd.… CISION PRNewswireMay 19, 2026
Hong Kong Gold Exchange Subsidiary GoldZip Names Midas Labs as Strategic Web3 Partner HONG KONG and SINGAPORE, May 19, 2026 /PRNewswire/ — Digital gold "GoldZip",… CISION PRNewswireMay 19, 2026
Z-COM Introduces Edge-Native Infrastructure Architecture Across CommunicAsia and Computex 2026 The company will present its edge-native infrastructure architecture at CommunicAsia 2026 in… CISION PRNewswireMay 19, 2026
Press ReleaseWIZ.AI Launches Wizlynn: A Reliable Multi-Agent Inbound Platform for Enterprises SINGAPORE, May 19, 2026 /PRNewswire/ — At the One North Foundation AI Community… CISION PRNewswireMay 19, 2026
Strider Report Reveals Scale of Australian and New Zealand Academic Research Done in Collaboration with PLA-affiliated Entities on STEM Technologies Strider identifies more than 6,000 joint publications and collaborations between researchers from… CISION PRNewswireMay 19, 2026
Cohesity Earns AWS Resilience Competency, Advancing Enterprise Cyber Recovery Strengthens global cyber resilience and enables multi-currency procurement through AWS Marketplace SINGAPORE,… CISION PRNewswireMay 19, 2026
Accro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases Financing led by OrbiMed with participation from TCGX, LAV, Cenova Capital and… CISION PRNewswireMay 19, 2026
Press ReleaseNAVER D2SF Invests in Clone Labs, an AI Startup That Predicts User Intent and Decisions – Developing a "User Model" that records and accumulates users’ computer and… CISION PRNewswireMay 19, 2026